Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Lab-on-a-Chip Asia
Conferences  \  Lab-on-a-Chip Asia  \  Agenda  \  Vincent Linder
RegisterLogin

Vincent Linder's Biography


Vincent Linder, CTO, OPKO Diagnostics

Dr. Linder serves as Chief Technology Officer at OPKO Diagnostics, a company focusing on the commercialization of clinical diagnostics products, including a high-performance Point-of-Care test system (Claros1TM) and a high-specificity laboratory test for prostate cancer (4KscoreTM). He is also a co-founder of Claros Diagnostics Inc. (now part of OPKO) and co-invented the Claros technology, while being a post-doctorate fellow in George Whitesides’ laboratory at Harvard University. Dr. Linder also worked as Group Leader in microfluidics at the University of Neuchatel (Switzerland), and has served as Research Scientist at CSEM (Switzerland), a leading company in micro/nanotechnology and microelectronics. He holds a M.Sc. in Chemistry and a Ph.D. in Science from the University of Neuchatel, where he performed research in the area of microfluidic technology for immunoassays with Prof. Nico de Rooij, one of the pioneers in the field of microfluidics.

 Vincent Linder Image

Commercialization of Microfluidic Devices for Point-of-Care Diagnostics

Wednesday, 13 November 2013 at 14:45

Add to Calendar ▼2013-11-12 08:00:002013-11-12 09:00:00Europe/LondonCommercialization of Microfluidic Devices for Point-of-Care DiagnosticsLab-on-a-Chip Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com

Microfluidics is a key component to designing devices for high-performance in-vitro diagnostics tests outside the laboratory.  The presentation will focus on generally applicable design rules for such devices, and a discussion of how these rules were successfully applied to the design of the Claros1TM device.  The presentation will focus on the interface between microfluidics and usability, robustness (for manufacturing), cost competitiveness and clinical performance from trials.

Commercialization of Microfluidic Devices for Point-of-Care Diagnostics

Wednesday, 13 November 2013 at 14:45

Add to Calendar ▼2013-11-12 08:00:002013-11-12 09:00:00Europe/LondonCommercialization of Microfluidic Devices for Point-of-Care DiagnosticsLab-on-a-Chip Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com

Microfluidics is a key component to designing devices for high-performance in-vitro diagnostics tests outside the laboratory.  The presentation will focus on generally applicable design rules for such devices, and a discussion of how these rules were successfully applied to the design of the Claros1TM device.  The presentation will focus on the interface between microfluidics and usability, robustness (for manufacturing), cost competitiveness and clinical performance from trials.


Add to Calendar ▼2013-11-12 00:00:002013-11-13 00:00:00Europe/LondonLab-on-a-Chip AsiaLab-on-a-Chip Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors